$62.35
-1.84-2.87%
Last update: Oct 5, 4:02 PM
$62.35
-1.84-2.87%
Arrowhead Pharmaceuticals Inc
ARWRNASDAQ
Arrowhead Pharma (ARWR) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.19 | $-1.14 | $0.02 | $-0.05 |
| Actual | $-1.36 | $-0.93 | $0.22 | $-0.18 |
| Surprise | -14.3% | +18.4% | +1000.0% | -260.0% |
| Revenue | ||||
| Estimate | $51.2M | $69.3M | $256.6M | $175.5M |
| Actual | $75.3M | $73.7M | $264.0M | $256.5M |
| Surprise | +47.1% | +6.45% | +2.89% | +46.1% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-1.55 | $-1.32 | $-1.27 | $-1.24 |
| Revenue | ||||
| Consensus | $60.2M | $46.8M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Aug 4, 2026 | $-1.36 | $-1.19 | -14.3 % |
| Q2 | May 7, 2026 | $-0.93 | $-1.14 | 18.4 % |
| Q1 | Feb 5, 2026 | $0.22 | $0.02 | 1000.0 % |
| Q4 | Nov 25, 2025 | $-0.18 | $-0.05 | -260.0 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Aug 4, 2026 | $75.25M | $51.15M | 47.1 % |
| Q2 | May 7, 2026 | $73.74M | $69.27M | 6.45 % |
| Q1 | Feb 5, 2026 | $264.03M | $256.62M | 2.89 % |
| Q4 | Nov 25, 2025 | $256.47M | $175.54M | 46.1 % |
